Contents

Search


Herpes zoster subunit vaccine

Dosage: - two doses were given 2 months apart Mechanism of action: - contains varicella zoster virus glycoprotein E plus an adjuvant Notes: - high efficacy in older adults [1] - 97% efficacy, with similar benefits across age groups [1] - cost effective in older adults [2]

General

Herpes zoster (shingles) vaccine (Zostavax, Shingrix)

References

  1. Lal H et al Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults. N Engl J Med. April 28, 2015 PMID: 25916341 http://www.nejm.org/doi/full/10.1056/NEJMoa1501184
  2. Le P, Rothberg, MB Cost-effectiveness of the Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults. JAMA Intern Med. Published online January 2, 2018. PMID: 29297049 https://jamanetwork.com/journals/jamainternalmedicine/article-abstract/2666789 - Najafzadeh M. Evolution of Herpes Zoster Vaccines and Their Economic Value. JAMA Intern Med. Published online January 2, 2018 PMID: 29297047 https://jamanetwork.com/journals/jamainternalmedicine/article-abstract/2666787